One case involved a 41-year-old woman who died of cardiac arrest in July. CBS says the documents are unverified and the drug's role in the deaths is still unclear.
Recap by typeshit. Full story at Yahoo.
MedPage Today
A JAMA Network Open analysis of Reddit posts also lists fatigue, insomnia and muscle symptoms. MedPage's roundup adds a CagriSema menopause analysis and Walmart's GLP-1 coverage plan.
A short teaser comparing how well people tolerate the two main GLP-1 ingredients, with the full breakdown behind the link.
Doctors quoted by Men's Journal raise concerns about how much GLP-1 users are paying for add-on supplements each month.
The anti-doping agency says many sellers use research chemical labels to dodge FDA scrutiny while selling peptides and SARMs.
17:56
DOWNSIZED looks at EASD 2026 data on an amylin-based drug reaching 23% weight loss and how it might stack up against retatrutide.
10:44
A personal account of a month on retatrutide, a drug still in trials and not approved for sale. It amounts to one person's anecdote, with no sourcing given.
Loading…